Compare SPAI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPAI | CBUS |
|---|---|---|
| Founded | 2021 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.0M | 69.9M |
| IPO Year | 2024 | 2017 |
| Metric | SPAI | CBUS |
|---|---|---|
| Price | $4.12 | $1.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $10.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 400.8K | 184.8K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,266,756.00 | ★ $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $629.15 | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.47 | $1.09 |
| 52 Week High | $9.16 | $3.40 |
| Indicator | SPAI | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 44.89 | 57.34 |
| Support Level | $3.97 | $1.59 |
| Resistance Level | $4.89 | $1.80 |
| Average True Range (ATR) | 0.49 | 0.14 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 55.12 | 65.15 |
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.